.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 6,693,115

« Back to Dashboard

Claims for Patent: 6,693,115

Title: Acid addition salts of hydropyridine derivatives
Abstract:Acid addition salts of 2-acetoxy-5-(.alpha.-cyclopropyl-carbonyl-2-fluorobenzyl)-4,5,6,7-tetrahyd rothieno[3,2-c]-pyridine. The acid addition salts of tetrahydrothienopyridine derivatives of the present invention exhibit excellent oral absorption, metabolization into the active compound, and platelet aggregation-inhibiting effects, low toxicity, and excellent storage and handling stabilities, and are useful as medicaments, preferably preventive or therapeutic agents (particularly therapeutic agents) for diseases caused by a thrombus or an embolus, still more preferably preventive or therapeutic agents (particularly therapeutic agents) for thrombosis or embolism.
Inventor(s): Asai; Fumitoshi (Tanashi, JP), Ogawa; Taketoshi (Tokyo, JP), Naganuma; Hideo (Tokyo, JP), Yamamura; Naotoshi (Nishitokyo, JP), Inoue; Teruhiko (Ube, JP), Nakamura; Kazuyoshi (Onoda, JP)
Assignee: Sankyo Company, Limited (Tokyo, JP) Ube Industries Ltd. (Ube, JP)
Application Number:10/329,629
Patent Claims: 1. 2-Acetoxy-5-(.alpha.-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydr othieno[3,2-c]pyridine hydrochloride.

2. 2-Acetoxy-5-(.alpha.-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydr othieno[3,2-c]pyridine maleate.

3. A medicament composition comprising a pharmaceutically effective amount of the salt according to claim 1 as an active ingredient in combination with a pharmaceutically acceptable carrier.

4. A medicament composition comprising a pharmaceutically effective amount of the salt according to claim 2 as an active ingredient in combination with a pharmaceutically acceptable carrier.

5. The medicament composition according to claim 3, wherein said medicament is for prevention or treatment of a thrombus formation-induced or an embolization-induced disease in a warm blooded animal.

6. The medicament composition according to claim 4, wherein said medicament is for prevention or treatment of a thrombosis or an embolism in a human.

7. The medicament composition according to claim 6, wherein said medicament is for treatment of a thrombosis or an embolism in a human.

8. A method for prevention or treatment of a thrombus formation-induced or an embolization-induced disease in a warm blooded animal which comprises administering an effective amount of the salt according to claim 1.

9. The method according to claim 8, wherein the warm blooded animal is a human.

10. The method according to claim 9, wherein the method is for treatment of a thrombosis.

11. The method according to claim 9, wherein the method is for treatment of an embolism.

12. A method for prevention or treatment of a thrombus formation-induced or an embolization-induced disease in a warm blooded animal which comprises administering an effective amount of the salt according to claim 2.

13. The method according to claim 12, wherein the warm blooded animal is a human.

14. The method according to claim 13, wherein the method is for treatment of a thrombosis.

15. The method according to claim 13, wherein the method is for treatment of an embolism.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc